Armstrong Grayson W, Miller John B
Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA 02114, USA.
Harvard Retinal Imaging Lab, Harvard Medical School, Boston, MA 02114, USA.
J Clin Med. 2022 Feb 5;11(3):835. doi: 10.3390/jcm11030835.
Use of ophthalmic telemedicine for patients with age-related macular degeneration (AMD) has shown remarkable advances over recent years. The recent COVID pandemic accelerated this transition since in-person evaluation of elderly patients at high risk for advanced AMD and severe vision loss were also at higher risk for complications from COVID infection. To date, ophthalmic telemedicine has been successfully used in remote retinal consultation by general ophthalmologists for AMD management, hybrid testing visits with both in-office testing and remote evaluation, as well as early successes in home-based remote monitoring of patients with high-risk AMD. We therefore review the current literature and evidence base related to ophthalmic telemedicine for AMD.
近年来，眼科远程医疗在年龄相关性黄斑变性（AMD）患者中的应用取得了显著进展。近期的新冠疫情加速了这一转变，因为对患有晚期AMD和严重视力丧失高风险的老年患者进行面对面评估时，他们感染新冠并发症的风险也更高。迄今为止，眼科远程医疗已成功应用于普通眼科医生对AMD进行远程视网膜会诊、结合门诊检查和远程评估的混合检查就诊，以及对高风险AMD患者进行家庭远程监测也取得了初步成功。因此，我们综述了与AMD眼科远程医疗相关的当前文献和证据基础。
